ICAM1 and small cell lung carcinoma: Since all of the NK cells used as effectors in ADCC assay abundantly express lymphocyte function–associated antigen (LFA)-1, a heterodimer of CD11a and CD18 (Supplementary Figure 5), we evaluated the expression of its counter receptor, ICAM-1, on target SCLC cells.